Skip to content
For Clinicians
For Patients
Our Technology
About Us
Resources
For Clinicians
For Patients
Our Technology
About Us
Resources
Contact Us
Portal Login
Application of LIVERFASt to Predict Steatosis in Chronic Hepatitis B Patients with Metabolic Syndrome
Application of LIVERFASt to Predict Steatosis in Chronic Hepatitis B Patients with Metabolic Syndrome
Aims for the study:
To evaluate the prognostic values of LIVERFASt as a noninvasive biomarker in detecting hepatic steatosis in chronic hepatitis B
 To correlate LIVERFASt steatosis with Fibroscan Controlled Attenuation Parameter (CAP) scores
Next
Meet our Team at AASLD 2024!
Next
Scroll to Top
Contact Us
Area of Interest
Sales
Product
Collaboration
Publications
Medical & Clinical
Submit